Nir Barzilai and Risa Starr at ARDD2025: Rebranding Aging: How to Talk About and Deliver Geroscience

Value of the Information & Strength of the Argument

The talk provides valuable insights into the strategic communication challenges facing the field of aging research. The argumentation is well-structured, presenting a clear problem (fragmentation and confusion), a proposed solution (unified branding under ‘geroscience’), and a detailed plan for implementation. The use of market research data, including interviews with over a thousand people, adds credibility. However, the talk is primarily an advocacy piece, and the evidence presented is anecdotal rather than peer-reviewed. The speakers acknowledge the need for scientific rigor but do not delve into the specifics of how the rebranding will be validated or how it will impact research outcomes.

Scientific Rigor, Source Quality, Title Accuracy

The talk does not cite specific scientific sources, but it references the involvement of organizations like the Academy for Health and Lifespan Research and the Longevity Biotech Association. The rebranding process is based on professional market research, which is not detailed in the talk. The title accurately reflects the content, focusing on rebranding and communication. The talk is not a scientific presentation but rather a strategic discussion, so the lack of citations is expected. The speakers do not provide references to specific studies or data, but they mention that the research was conducted by a professional agency. The talk is part of a conference (ARDD2025), which lends some credibility, but the content is opinion-based.

The title accurately reflects the content, which focuses on rebranding and communicating geroscience.

7/10

The talk presents a strategic rebranding initiative based on market research and stakeholder interviews, but it is primarily an opinion/advocacy piece without peer-reviewed data or detailed methodology.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by Nir Barzilai, setting the stage for the rebranding initiative.
• 02:00Barzilai presents the vision and mission statements developed by the rebranding agency.
• 04:00Discussion of the problem: too many terms, confusion, and hype in the field.
• 06:00Barzilai explains the decision to use 'geroscience' as the unifying term, despite initial resistance.
• 08:00Risa Starr takes over, detailing the research process: interviews, focus groups, and surveys.
• 10:00Starr discusses the need for scientific legitimacy and separating from pseudoscience.
• 12:00Starr outlines the program roadmap, including website launch and media campaigns.
• 14:00Starr presents the metrics-driven approach and tools for monitoring success.
• 16:00Q&A session: audience member raises concerns about political framing and clinical research.
• 18:00Barzilai responds to questions, emphasizing the need for education and collaboration.

• ARDD Conference Website — The talk was presented at the 12th Aging Research and Drug Discovery meeting.
• Academy for Health and Lifespan Research — Risa Starr is the executive director of this organization, which is part of the rebranding initiative.
• Longevity Biotech Association — One of the four organizations involved in the rebranding effort.

• Geroscience: The emerging field of aging biology — Supports the definition and importance of geroscience as a field.
• The Hallmarks of Aging — Provides scientific background on the biology of aging, which underpins geroscience.

• Anti-aging medicine: a critique — This article critiques the anti-aging movement, which the talk positions as the 'enemy' to distinguish from geroscience.